← Leaderboards
Robert W Clarke
Pulmatrix
$2,179,405
Attributed
$2,179,405
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $728.1K · FY2009–13$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$2,179,405 · 1
By mechanism
U01$2,179,405 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Aerosol Drug Therapy”
- Jorge L. Benach · State University New York Stony Brook$13,281,618
- William Robert Jacobs · Albert Einstein College Of Medicine$9,414,005
- Daniel G Baden · University Of North Carolina Wilmington$8,199,260
- Michael B Oldstone · Scripps Research Institute$8,108,774
- Larry Zeitlin · Epicyte Pharmaceutical, Inc.$7,930,858
- Rhea N Coler · Access To Advanced Health Institute$7,779,213
Research focus
Aerosol Drug TherapyAerosolsAids/Hiv ProblemBacteriaBacterial PneumoniaBaseBreathingBurden Of IllnessCalciumCategoriesCationsCell Culture TechniquesClinical EfficacyCombatCommunicable DiseasesContagionCoughingDosage FormsDoseDrug FormulationsEpithelial CellsExhalationFamily SuidaeAcute
Grant awards (5)
Inhaled aerosols for prevention and treatment of respiratory infections$102,851
U01 · FY2013 · AI · contact PI
Inhaled aerosols for prevention and treatment of respiratory infections$283,013
U01 · FY2012 · AI · contact PI
Inhaled aerosols for prevention and treatment of respiratory infections$365,861
U01 · FY2011 · AI · contact PI
Inhaled aerosols for prevention and treatment of respiratory infections$699,622
U01 · FY2010 · AI · contact PI
Inhaled aerosols for prevention and treatment of respiratory infections$728,058
U01 · FY2009 · AI · contact PI